CSIMarket
 
Moderna Inc   (NASDAQ: MRNA)
 

Moderna Inc's Suppliers Performance

MRNA's Supply Chain




 
MRNA Costs vs Sales of Suppliers Growth Moderna Inc's cost of sales deteriorated by -21.85 % year on year, relative to one quarter ago cost of sales fell by -90.26 % in Q2.

• More on MRNA Suppliers



Moderna Inc's cost of sales deteriorated by -21.85 % year on year, compare to one quarter ago cost of sales fell by -90.26 % in Q2.

• More on MRNA Suppliers




Moderna Inc's Comment on Supply Chain


The company produces products based on clinical and preclinical requirements using raw materials and components. It collaborates with external vendors to characterize critical raw materials, evaluate vendor quality systems, and ensure regulatory compliance. The company has infrastructure for direct-to-customer shipments and employs third-party wholesalers alongside AI-driven data analytics for ordering and delivery. Its global engineering organization works with external and internal service providers to implement robotics, automation, and predictive analysis in facility operations. AI is integrated across the value chain, including drug design, clinical trial operations, manufacturing, and commercialization, to improve efficiency and performance.

Moderna Inc's Comment on Supply Chain


The company produces products based on clinical and preclinical requirements using raw materials and components. It collaborates with external vendors to characterize critical raw materials, evaluate vendor quality systems, and ensure regulatory compliance. The company has infrastructure for direct-to-customer shipments and employs third-party wholesalers alongside AI-driven data analytics for ordering and delivery. Its global engineering organization works with external and internal service providers to implement robotics, automation, and predictive analysis in facility operations. AI is integrated across the value chain, including drug design, clinical trial operations, manufacturing, and commercialization, to improve efficiency and performance.







MRNA's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Moderna Inc 79,154.24 2,228.00 -3,151.00 4,700
SUBTOTAL 0.00 0.00 0.00 -


Sources: Moderna Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Moderna Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.